Asymmetric corticomotor excitability correlations in early Parkinson's disease

被引:32
|
作者
Wu, Allan D.
Petzinger, Giselle M.
Lin, Chien-Ho J.
Kung, Myron
Fisher, Beth
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[2] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA
[3] Univ So Calif, Sch Dent, Dvi Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA
关键词
cortical excitability; motor evoked potentials; silent period; Parkinson's disease; transcranial magnetic stimulation;
D O I
10.1002/mds.21565
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied corticomotor excitability (CE) between the more and less affected sides in early Parkinson's disease (PD) patients using transcranial magnetic stimulation (TMS). Sixteen-PD patients within the first 3 years of diagnosis were studied with single-pulse TMS over each motor cortex with intensities from 40% to 100% stimulator output. Active motor evoked potentials (MEP) and cortical silent period durations (CSP) were recorded, fitted with sigmoid curves, summarized as maximal MEP/CSP, maximal MEP/CSP slope, and intensity where MEP/CSP is half-maximal (MEP/CSP-Int50), and correlated with Unified Parkinson's Disease Rating Scale scores (UPDRS). On the more affected side, higher (worse) UPDRS scores were correlated with shorter maximal CSP (r = -0.51, P = 0.046). On the less affected side, higher UPDRS scores were correlated with higher MEP-Int50 (r = 0.5 1, P = 0.043) and CSP-Int50 (r = 0.54, P = 0.029). For the less affected side, altered CE, as indexed by higher MEP or CSP-Int50 intensities, may contribute to early clinical symptoms. On the more affected side, increases in CE, indexed by shorter CSP, may account for a greater proportion of PD symptoms. These findings are consistent with an evolution of neurophysiologic correlates in early PD patients from a less to more symptomatic state. (c) 2007 Movement Disorder Society.
引用
收藏
页码:1587 / 1593
页数:7
相关论文
共 50 条
  • [41] Fatigue in early Parkinson's disease
    秦朝晖
    China Medical Abstracts (Internal Medicine), 2012, (04) : 237 - 238
  • [42] Treatment of early Parkinson's disease
    Marsh, L
    Dawson, TM
    BRITISH MEDICAL JOURNAL, 2000, 321 (7252): : 1 - 2
  • [43] Treatment of early Parkinson's disease
    Koller, WC
    NEUROLOGY, 2002, 58 (04) : S79 - S86
  • [44] Early diagnosis in Parkinson's disease
    Juri Claveria, Carlos Andres
    Uribe San Martin, Reinaldo
    SALUD I CIENCIA, 2009, 16 (08): : 839 - 844
  • [45] Early diagnosis of Parkinson's disease
    Spiegel, Joerg
    Storch, Alexander
    Jost, Wolfgang H.
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 4) : 2 - 7
  • [46] Apathy in early Parkinson's disease
    Stojkovic, T.
    Stankovic, I.
    Tomic, A.
    Jecmenica, M.
    Kresojevic, N.
    Mandic, G.
    Markovic, V.
    Stefanova, E.
    Svetel, M.
    Miskovic, N.
    Petrovic, I.
    Kostic, V. S.
    JOURNAL OF NEUROLOGY, 2014, 261 : S244 - S244
  • [47] EARLY DIAGNOSIS OF PARKINSON'S DISEASE
    Gaenslen, Alexandra
    Berg, Daniela
    TRANSCRANIAL SONOGRAPHY IN MOVEMENT DISORDERS, 2010, 90 : 81 - 92
  • [48] Treatment of early Parkinson's disease
    Dickerson, LM
    Young, SE
    Simpson, WM
    Nashelsky, J
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (03) : 497 - 500
  • [49] Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease
    Kamble, Nitish
    Bhattacharya, Amitabh
    Hegde, Shantala
    Vidya, N.
    Gothwal, Mohit
    Yadav, Ravi
    Pal, Pramod Kumar
    BEHAVIOURAL BRAIN RESEARCH, 2022, 422
  • [50] Treatment of early Parkinson's disease
    Grimes, DA
    Lang, AE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S39 - S44